Even within the human type I IFN family, there are controversial results in different cell lines: IFN-β is more potent than IFN-α in human melanoma cells, but equivalent effect from IFN-α and IFN-β stimulation have been observed in human dermal microvascular endothelial cells [11], [57]. The gene discussed is IFNA2; the disease is melanoma.